The aim of the present study was to investigate whether common and low-frequency variation in AGPAT6, encoding a novel GPAT enzyme, GPAT4, was associated with type 2 diabetes, obesity, dyslipidemia or indices of insulin resistance and insulin secretion in a large Danish population. The gene discussed is GPAT4; the disease is obesity due to melanocortin 4 receptor deficiency.